D
Satellos Bioscience Inc.
MSCLF
$0.52
$0.00611.19%
D
Sell
9/19/2024Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 9/19/2024 due to an increase in the volatility index and total return index.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 9/19/2024 due to an increase in the volatility index and total return index.
E
Sell
9/4/2024Downgrade
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 9/4/2024 due to a decline in the solvency index, volatility index and growth index. The quick ratio declined from 9.07 to 7.13.
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 9/4/2024 due to a decline in the solvency index, volatility index and growth index. The quick ratio declined from 9.07 to 7.13.
D
Sell
3/25/2024Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 3/25/2024 due to an increase in the volatility index, total return index and valuation index.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 3/25/2024 due to an increase in the volatility index, total return index and valuation index.
E
Sell
3/8/2024Downgrade
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 3/8/2024 due to a decline in the volatility index and valuation index.
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 3/8/2024 due to a decline in the volatility index and valuation index.
D
Sell
2/16/2024Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 2/16/2024 due to an increase in the volatility index and total return index.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 2/16/2024 due to an increase in the volatility index and total return index.
E
Sell
2/1/2024Downgrade
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 2/1/2024 due to a decline in the solvency index and volatility index. The quick ratio declined from 24.74 to 19.26.
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 2/1/2024 due to a decline in the solvency index and volatility index. The quick ratio declined from 24.74 to 19.26.
D
Sell
9/5/2023Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 9/5/2023 due to a noticeable increase in the solvency index, growth index and total return index. The quick ratio increased from 0.99 to 24.74, and debt to equity declined from 0.95 to 0.04.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 9/5/2023 due to a noticeable increase in the solvency index, growth index and total return index. The quick ratio increased from 0.99 to 24.74, and debt to equity declined from 0.95 to 0.04.
E
Sell
4/17/2023Downgrade
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 4/17/2023 due to a large decline in the growth index, valuation index and solvency index. Earnings per share declined from -$0.0417 to -$0.0894, the quick ratio declined from 1.66 to 0.77, and EBIT declined 12.8% from -$1.4M to -$1.58M.
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 4/17/2023 due to a large decline in the growth index, valuation index and solvency index. Earnings per share declined from -$0.0417 to -$0.0894, the quick ratio declined from 1.66 to 0.77, and EBIT declined 12.8% from -$1.4M to -$1.58M.
D
Sell
4/3/2023Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 4/3/2023 due to an increase in the volatility index and total return index.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 4/3/2023 due to an increase in the volatility index and total return index.
E
Sell
3/14/2023Downgrade
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 03/14/2023.
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 03/14/2023.
D
Sell
2/23/2023Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 2/23/2023 due to an increase in the total return index and volatility index.
E
Sell
2/8/2023Downgrade
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the total return index.
D
Sell
11/25/2022Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 11/25/2022 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.0531 to -$0.0417, and EBIT increased 18.64% from -$1.73M to -$1.4M.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 11/25/2022 due to a major increase in the growth index and valuation index. Earnings per share increased from -$0.0531 to -$0.0417, and EBIT increased 18.64% from -$1.73M to -$1.4M.
E
Sell
10/28/2022Downgrade
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 10/28/2022 due to a decline in the valuation index.
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 10/28/2022 due to a decline in the valuation index.
D
Sell
10/13/2022Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 10/13/2022 due to an increase in the volatility index and valuation index.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 10/13/2022 due to an increase in the volatility index and valuation index.
E
Sell
8/16/2022Downgrade
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 8/16/2022 due to a decline in the volatility index and valuation index.
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 8/16/2022 due to a decline in the volatility index and valuation index.
D
Sell
8/1/2022Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 8/1/2022 due to an increase in the volatility index.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 8/1/2022 due to an increase in the volatility index.
E
Sell
5/19/2022Downgrade
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 5/19/2022 due to a decline in the volatility index.
Satellos Bioscience Inc. (MSCLF) was downgraded to E+ from D- on 5/19/2022 due to a decline in the volatility index.
D
Sell
5/4/2022Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
Satellos Bioscience Inc. (MSCLF) was upgraded to D- from E+ on 5/4/2022 due to an increase in the volatility index and total return index.
E
Sell
5/1/2022Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to E+ from E on 5/1/2022 due to an increase in the solvency index and volatility index.
Satellos Bioscience Inc. (MSCLF) was upgraded to E+ from E on 5/1/2022 due to an increase in the solvency index and volatility index.
E
Sell
2/1/2022Upgraded
Satellos Bioscience Inc. (MSCLF) was upgraded to E from E- on 2/1/2022 due to a significant increase in the solvency index, efficiency index and valuation index. Total capital increased 3,533.87% from -$281.4 to $9.66M, and the quick ratio increased from 0.72 to 3.28.
Satellos Bioscience Inc. (MSCLF) was upgraded to E from E- on 2/1/2022 due to a significant increase in the solvency index, efficiency index and valuation index. Total capital increased 3,533.87% from -$281.4 to $9.66M, and the quick ratio increased from 0.72 to 3.28.
E
Sell
11/10/2021None
Satellos Bioscience Inc. (MSCLF) was downgraded to E- from U on 11/10/2021.
Satellos Bioscience Inc. (MSCLF) was downgraded to E- from U on 11/10/2021.
OTC PK
04/02/2025 2:07PM Eastern
Quotes delayed
